| scholarly article | Q13442814 |
| P2093 | author name string | T Wong | |
| R J Simonds | |||
| M A Chiasson | |||
| V Loo | |||
| A Reggy | |||
| J Heffess | |||
| P2860 | cites work | The effects of immune status and race on health service use among people with HIV disease. | Q52882917 |
| Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe | Q57181397 | ||
| Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons | Q68207124 | ||
| Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens | Q24534391 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| The use of health services by women with HIV infection | Q33725210 | ||
| Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group | Q33745869 | ||
| Natural history of HIV infection in the era of combination antiretroviral therapy | Q33876280 | ||
| Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. | Q34067875 | ||
| Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. | Q34068078 | ||
| A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team | Q34438252 | ||
| Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study | Q36247045 | ||
| Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group | Q38500450 | ||
| Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). | Q39226545 | ||
| Racial differences in the use of drug therapy for HIV disease in an urban community | Q39397888 | ||
| Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group | Q43898486 | ||
| Declining HIV/AIDS mortality in New York City. | Q50644909 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV/AIDS | Q12199 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 492-500 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Journal of Urban Health | Q15760615 |
| P1476 | title | Antiretroviral therapy and declining AIDS mortality in New York City | |
| P478 | volume | 77 |
| Q37626445 | Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City |
| Q35098544 | HIV/AIDS mortality in trends in Canada, 1987-1998. |
| Q45732628 | Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease |
| Q34940422 | Mortality trends and disparities among racial/ethnic and sex subgroups in New York City, 1990 to 2000. |
| Q35543516 | Palliative Care for AIDS at a Large Urban Teaching Hospital: Program Description and Preliminary Outcomes |
| Q53371778 | Palliative Care for AIDS: Challenges and Opportunities in the Era of Highly Active Anti-Retroviral Therapy |
| Q40953520 | Profile analysis of patients with HIV/AIDS hospitalized after the introduction of antiretroviral therapy |
| Q34631672 | Selected metabolic and morphologic complications associated with highly active antiretroviral therapy |
| Q37837886 | Substance use in the MSM population of New York City during the era of HIV/AIDS. |
| Q34631679 | Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients |
Search more.